Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoram Reiter

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Cancer Research|October 18, 2002
Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cellsCyril J Cohen, Noa Hoffmann, Marganit Farago, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
Nano Letters|September 14, 2006
Antibody molecules discriminate between crystalline facets of a gallium arsenide semiconductorArbel Artzy Schnirman, Efrat Zahavi, Hadas Yeger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexesWilliam E Biddison, Richard V Turner, Susan J Gagnon, et al.
Cancer Research|October 3, 2008
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibitionIlenia Pellicciotta, Xochitl Cortez-Gonzalez, Roman Sasik, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivoAvital Lev, Roy Noy, Kfir Oved, et al.
Journal of Immunological Methods|June 12, 2003
Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHCCyril J Cohen, Galit Denkberg, Yael S Schiffenbauer, et al.
Nano Letters|September 16, 2008
A two-state electronic antigen and an antibody selected to discriminate between these statesArbel Artzy-Schnirman, Elad Brod, Malki Epel, et al.
Expert Review of Anticancer Therapy|October 28, 2005
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapyRoy Noy, Malka Eppel, Maya Haus-Cohen, et al.
Journal of Autoimmunity|October 5, 2013
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitopeRony Dahan, John A Gebe, Anton Preisinger, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cancer Research|October 18, 2002
Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cellsCyril J Cohen, Noa Hoffmann, Marganit Farago, et al.
Cancer Research|August 5, 2008
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenograftsEynav Klechevsky, Michael Gallegos, Galit Denkberg, et al.
Nano Letters|September 14, 2006
Antibody molecules discriminate between crystalline facets of a gallium arsenide semiconductorArbel Artzy Schnirman, Efrat Zahavi, Hadas Yeger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexesWilliam E Biddison, Richard V Turner, Susan J Gagnon, et al.
Cancer Research|October 3, 2008
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibitionIlenia Pellicciotta, Xochitl Cortez-Gonzalez, Roman Sasik, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2004
Tumor-specific Ab-mediated targeting of MHC-peptide complexes induces regression of human tumor xenografts in vivoAvital Lev, Roy Noy, Kfir Oved, et al.
Journal of Immunological Methods|June 12, 2003
Simultaneous monitoring of binding to and activation of tumor-specific T lymphocytes by peptide-MHCCyril J Cohen, Galit Denkberg, Yael S Schiffenbauer, et al.
Nano Letters|September 16, 2008
A two-state electronic antigen and an antibody selected to discriminate between these statesArbel Artzy-Schnirman, Elad Brod, Malki Epel, et al.
Expert Review of Anticancer Therapy|October 28, 2005
T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapyRoy Noy, Malka Eppel, Maya Haus-Cohen, et al.
Journal of Autoimmunity|October 5, 2013
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitopeRony Dahan, John A Gebe, Anton Preisinger, et al.
Pageof 8